Ollenschläger Günter, Kopp Ina
Arztliches Zentrum für Qualität in der Medizin (AZQ) - gemeinsames Institut von Bundesärztekammer und Kassenärztlicher Bundesvereinigung, Berlin, Germany.
Med Klin (Munich). 2007 May 15;102(5):383-7. doi: 10.1007/s00063-007-1052-1.
The Program for National Disease Management Guidelines (German DM-CPG Program) is a joint initiative of the German Medical Association (umbrella organization of the German Chambers of Physicians), the Association of the Scientific Medical Societies (AWMF), and of the National Association of Statutory Health Insurance Physicians (NASHIP). The program aims at developing, implementing and continuously updating best-practice recommendations for countrywide and regional disease management programs in Germany. Since 2003 twelve national guidelines (topics: asthma, chronic obstructive pulmonary disease, HI (Chronic heart failure), CVD (Chronic coronary heart disease) back pain, depression, several aspects of diabetes) have been produced by use of a standardized procedure in accordance with internationally consented methodologies. For countrywide dissemination and implementation the program uses a wide range of specialist journals, continuous medical education and quality management programs. So far, 36 out of 150 national scientific medical associations, four allied health profession organizations, and twelve national consumer organizations have been participating in the DM-CPG Program. Studies to evaluate the program's effects on health-care providers' behavior and patients' outcomes are under way.
国家疾病管理指南项目（德国糖尿病临床实践指南项目）是德国医学协会（德国医师协会的伞式组织）、科学医学协会联盟（AWMF）以及法定医疗保险医师全国协会（NASHIP）的一项联合倡议。该项目旨在为德国全国性和地区性疾病管理项目制定、实施并持续更新最佳实践建议。自2003年以来，已按照国际认可的方法，通过标准化程序制定了12项国家指南（主题包括：哮喘、慢性阻塞性肺疾病、心力衰竭、慢性冠状动脉疾病、背痛、抑郁症、糖尿病的多个方面）。为了在全国范围内传播和实施，该项目利用了各种专业期刊、继续医学教育和质量管理项目。到目前为止，150个全国性科学医学协会中的36个、4个联合健康专业组织以及12个全国性消费者组织参与了糖尿病临床实践指南项目。评估该项目对医疗服务提供者行为和患者治疗结果影响的研究正在进行中。
